On October 21, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria and GBCHealth hosted a virtual dialogue on the role of the private sector in developing and scaling new tools in the fight Against AIDS, TB, malaria and emerging pandemics. The dialogue explored how private sector innovations in prevention, diagnostics, treatment and delivery are shaping the response and effort to end the HIV/AIDS, TB and malaria epidemics across the globe. Speakers also discussed the impact of COVID-19 on the three diseases, and why the global health community must continue to remain committed to innovation.

Panelists include:
-Philippe Jacon, Senior Vice-President, Global Access, Cepheid
-Michael Joos, CEO, Vestergaard
-Helen McDowell, Head of Government Affairs & Global Public Health, ViiV Healthcare
-Zeda Rosenberg, Founder and CEO, International Partnership on Microbicides
-Mark Lagon Chief Policy Officer, Friends of the Global Fight (Moderator)

Observations:
-Nancy Wildfeir-Field, President, GBCHealth
-Chris Collins, President & CEO, Friends of the Global Fight